Aryabhatta Sadhu to Present Multivariable Predictors of Bleeding in Prophylactic Transfusion at ISBT 2025
Aryabhatta Sadhu, Senior Resident Doctor at AIIMS, shared on LinkedIn:
”From “more platelets” to “smarter transfusions.”
At International Society of Blood Transfusion (ISBT) 2025 (Perth), I’ll be presenting Poster BP061 — “Multivariable Predictors of Bleeding in Prophylactic Transfusion: Coagulopathy and Refractoriness Outweigh Platelet Concentrate Dosage.”
Our findings challenge the long-held “dose-response” paradigm in prophylactic transfusion.
Despite higher platelet increments with high-dose transfusions, bleeding outcomes remained unchanged.
Instead, coagulopathy (DIC) and refractoriness (spleen size, fever, chemo timing) emerged as the true drivers of bleeding risk.
This work pushes toward personalized, coagulation-integrated transfusion strategies—a necessary shift for safer, patient-centered care.
Poster: BP061, Exhibition hall, ground level, Perth convention and exhibition centre.
Venue: International Society of Blood Transfusion (ISBT) 2025, Perth, WA, Australia.
Colleagues and collaborators in transfusion medicine, hematology, and clinical research are welcome to connect for further discussions.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis